Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P. John Butler

Affiliations

  • Director at Zynerba Pharmaceuticals Inc. (ZYNE), 2019-06-13
  • Ceo And President at Akebia Therapeutics Inc. (AKBA), 2019-06-05
  • Director at Keryx Biopharmaceuticals Inc (KERX), 2017-06-20
  • Director at Relypsa Inc (RLYP), 2016-09-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ZYNE $6.43 5,000 Director 5,000 2018-08-22 Filing
AKBA $11.57 1,000 Officer, Director 48,350 2014-12-29 Filing
AKBA $11.92 1,000 Officer, Director 47,350 2014-12-22 Filing
AKBA $11.34 1,000 Officer, Director 46,350 2014-12-15 Filing
AKBA $10.31 1,000 Officer, Director 45,350 2014-11-12 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RLYP $19.32 1,013 Director 2,849 2016-06-07 Filing
RLYP $34.62 1,100 Director 3,862 2015-06-11 Filing